This webinar focuses on the latest developments of the Chinese market landscape, industry dynamics, and access environment.
Participants will:
- Learn more about the macro drivers for pharma market growth in China, key trends around R&D and innovations, regulations and approvals, access and reimbursement – with a particular focus on the future outlook.
- Deep-dive into opportunities and challenges with market access in China, including early access programs, commercial health insurance, NRDL listing and renewals, as well as volume-based procurement.
- Gain insights into strategies in order to capitalize on emerging levers and innovate on access and go-to-market models in China.
By attending this webinar, participants will get a good understanding of the key factors that have been driving and shaping the Chinese pharma market to date, and more importantly, understand key actions to stay on top of the changes and get ahead of the curve.
This event is free of charge.
